Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Starting Date 1 Jan 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Marie Curie Grant Agreement Number 101227453 Is the Job related to staff position within a
-
Fixed-term: The funds for this post are available for 3 years. A doctoral studentship is available in the forthcoming Aspirational Computing Lab (February 2026) in the Department of Computer
-
project entitled: “Development and application of computational tools for the early detection and deconstruction of chromosomal instability in cancer” For further information about the research group
-
Fixed-term: The funds for this post are available for 12 months A position is available for a Postdoctoral Research Associate (Postdoc) in the forthcoming Aspirational Computing Lab in
-
Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical engineering, computational neuroscience
-
the field of Computational Morphodynamics in plants. The work will be within the ERC-funded project RESYDE (https://resydeproject.org ) with the aim of building a virtual flower using multi-level data and
-
-sequencing, flow cytometry, multiplex immunofluorescence, and standard molecular biology and biochemistry techniques. A computational component may also be available, depending on the skills and preference
-
to the launch of the Bloomberg Cambridge University Corporate Bond Index later in 2025 and the delivery of the ongoing research programme related to the index project. The successful candidate will undertake desk
-
transcriptomics and histone mark profiling as well as by live imaging approaches. As part of this project, you will have the opportunity to gain computational data analysis skills. This studentship comes with
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...